Welcome Guest to Happi

Subscribe Free: Magazine | eNewsletter

current issue November 2014
 •  President Signs Sunscreen Innovation Act  •  Rob Lowe, The Formulator  •  Body Shop Donating To War Child  •  L’Oréal To Honor Social Responsibility in Dermatology  •  Clariant Reaches ISO22716 and EFfci GMP Milestone
Print

Despite Toothpaste Woes, Analysts Like Colgate



Published July 12, 2007
Related Searches: men colgate share innovation
Post a comment
Colgate-Palmolive made headlines last month when several counterfeit tubes of toothpaste were found to contain diethylene glycol, a sweet-tasting, but potentially dangerous chemical.

Despite the bad PR, Morgan Stanley upgraded Colgate to Overweight, citing cost savings, strong operating fundamentals and the weak dollar as providing a potential upside to earnings estimates.

Meanwhile, Zacks senior consumer goods analyst Steven Ralston, CFA reiterated his Hold rating for shares of Colgate-Palmolive. He noted that Colgate has had a stellar long-term growth record, as well as a history of tight financial controls and new product innovations.


blog comments powered by Disqus